Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium bisulfite is a small molecule compound with the approximate chemical formula NaHSO3. It appears as white or yellowish-white crystals with a sulfurous odor. Sodium bisulfite is used in parenteral nutrition products for patients with severe liver disorders and has been applied externally for parasitic skin diseases and as a gastrointestinal antiseptic. In addition to its pharmaceutical uses, it serves as a reducing agent in various industrial applications, including food preservation (E number E222), cosmetics, and bleaching processes. Mechanistically, it acts primarily as an antioxidant/reducing agent; it can also deaminate cytosine residues in single-stranded DNA via sulfonation[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium bisulfite.